FFCP PHASE1:Hg19::chr3:18486324..18486338,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p4@TBC1D5 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_4_at_TBC1D5_5end |
Coexpression cluster: | C712_thymus_biphenotypic_CD4_non_granulocyte_merkel_acute |
Association with transcript: | -15bp_to_ENST00000414318_5end |
EntrezGene: | TBC1D5 |
HGNC: | 19166 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p4@TBC1D5 |
---|
0
10
20
30
40
50
60
70
80
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
T cell | 6.85e-30 | 25 |
pro-T cell | 6.85e-30 | 25 |
hematopoietic stem cell | 9.02e-29 | 168 |
lymphoid lineage restricted progenitor cell | 1.13e-26 | 52 |
hematopoietic cell | 3.56e-26 | 177 |
lymphocyte | 6.00e-26 | 53 |
common lymphoid progenitor | 6.00e-26 | 53 |
hematopoietic oligopotent progenitor cell | 1.90e-25 | 161 |
hematopoietic multipotent progenitor cell | 1.90e-25 | 161 |
mature alpha-beta T cell | 1.41e-23 | 18 |
Showing 1 to 10 of 19 entries
Ontology term | p-value | n |
---|---|---|
blood | 3.68e-11 | 15 |
haemolymphatic fluid | 3.68e-11 | 15 |
organism substance | 3.68e-11 | 15 |
thymus | 8.39e-07 | 4 |
hemolymphoid system gland | 8.39e-07 | 4 |
thymic region | 8.39e-07 | 4 |
pharyngeal gland | 8.39e-07 | 4 |
thymus primordium | 8.39e-07 | 4 |
Showing 1 to 8 of 8 entries
Ontology term | p-value | n |
---|---|---|
leukemia | 2.29e-18 | 39 |
myeloid leukemia | 3.22e-15 | 31 |
hematologic cancer | 9.39e-15 | 51 |
immune system cancer | 9.39e-15 | 51 |
Showing 1 to 4 of 4 entries